1997
DOI: 10.1016/s0041-1345(97)00534-4
|View full text |Cite
|
Sign up to set email alerts
|

Major histocompatibility complex class II antigen expression is suppressed by estradiol in cardiac allografts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1998
1998
2003
2003

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…27 The present study confirms that hypercholesterolemia increases the prevalence of early intimal lesions in the transplanted hearts; this has been documented 4 weeks after implantation in cholesterol-fed animals. 28,29 Acceleration of the proliferative vascular damage by a factor of 3 to 4 is seen with cholesterol feeding, but frequency or severity of lesions is unchanged in chronically rejecting rat aortic allografts in the absence of hypertriglyceridemia 30 and in apoE-deficient recipients of allotransplants. 31 Cholesterol feeding has a limited effect on normal arteries, as shown in coronary arteries of control and native hypercholesterolemic animals.…”
Section: Intimal Hyperplasiamentioning
confidence: 99%
“…27 The present study confirms that hypercholesterolemia increases the prevalence of early intimal lesions in the transplanted hearts; this has been documented 4 weeks after implantation in cholesterol-fed animals. 28,29 Acceleration of the proliferative vascular damage by a factor of 3 to 4 is seen with cholesterol feeding, but frequency or severity of lesions is unchanged in chronically rejecting rat aortic allografts in the absence of hypertriglyceridemia 30 and in apoE-deficient recipients of allotransplants. 31 Cholesterol feeding has a limited effect on normal arteries, as shown in coronary arteries of control and native hypercholesterolemic animals.…”
Section: Intimal Hyperplasiamentioning
confidence: 99%
“…70 Importantly, dietary L-arginine has been shown to attenuate the structural changes of transplant vasculopathy in vivo associated with downregulation of insulin-like growth factor-I and interleukin-6. 71 The literature supports a protective role for eNOS. In a murine chronic-rejection model, transplant atherosclerosis is accelerated in aortic allografts of eNOS-deficient mice.…”
Section: Does No Deficiency Play a Role In The Progression Of Transplmentioning
confidence: 98%